Evidence map›Paper›PMID 27457254›Full record

ArticleInfection control and hospital epidemiology2016

Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.

Elise M Martin, Dana Russell, Zachary Rubin, Romney Humphries, Tristan R Grogan, David Elashoff, Daniel Z Uslan

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Infection control and hospital epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Discontinuing contact precautions for COVID-19: the science says its time.Infection control and hospital epidemiology · 2026
    Article
  4. Article
  5. Article
  6. Ten sustainable steps infectious diseases professionals can take to mitigate the climate crisis.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Review
  7. Contact precautions for MRSA and VRE: where are we now? A survey of theAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  8. Article
  9. Article
  10. Contact precautions for the control of endemic pathogens: Finding the middle path.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Observational
  19. Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus Among Adult Intensive Care Unit Patients Following State-Mandated Active Surveillance.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elise M Martin1Division of Infectious Diseases,David Geffen School of Medicine at University of California-Los Angeles (UCLA),Los Angeles,California.
Dana Russell2Clinical Epidemiology and Infection Prevention,UCLA Health,Los Angeles,California.
Zachary Rubin1Division of Infectious Diseases,David Geffen School of Medicine at University of California-Los Angeles (UCLA),Los Angeles,California.
Romney Humphries3Department of Pathology and Laboratory Medicine,UCLA Health,Los Angeles,California.
Tristan R Grogan4Department of Medicine Statistics Core,David Geffen School of Medicine at UCLA,Los Angeles,California.
David Elashoff4Department of Medicine Statistics Core,David Geffen School of Medicine at UCLA,Los Angeles,California.
Daniel Z Uslan1Division of Infectious Diseases,David Geffen School of Medicine at University of California-Los Angeles (UCLA),Los Angeles,California.
University of California, Los Angeles · USUCLA Health · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001881
6 · The paper itself

Abstract

OBJECTIVE To evaluate the impact of discontinuation of contact precautions (CP) for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) and expansion of chlorhexidine gluconate (CHG) use on the health system. DESIGN Retrospective, nonrandomized, observational, quasi-experimental study. SETTING Two California hospitals. PARTICIPANTS Inpatients. METHODS We compared hospital-wide laboratory-identified clinical culture rates (as a marker of healthcare-associated infections) 1 year before and after routine CP for endemic MRSA and VRE were discontinued and CHG bathing was expanded to all units. Culture data from patients and cost data on material utilization were collected. Nursing time spent donning personal protective equipment was assessed and quantified using time-driven activity-based costing. RESULTS Average positive culture rates before and after discontinuing CP were 0.40 and 0.32 cultures/100 admissions for MRSA (P=.09), and 0.48 and 0.40 cultures/100 admissions for VRE (P=.14). When combining isolation gown and CHG costs, the health system saved $643,776 in 1 year. Before the change, 28.5% intensive care unit and 19% medicine/surgery beds were on CP for MRSA/VRE. On the basis of average room entries and donning time, estimated nursing time spent donning personal protective equipment for MRSA/VRE before the change was 45,277 hours/year (estimated cost, $4.6 million). CONCLUSION Discontinuing routine CP for endemic MRSA and VRE did not result in increased rates of MRSA or VRE after 1 year. With cost savings on materials, decreased healthcare worker time, and no concomitant increase in possible infections, elimination of routine CP may add substantial value to inpatient care delivery. Infect Control Hosp Epidemiol 2016;1-8.

Indexed as

Cross InfectionHospital CostsAcademic Medical CentersAnti-Infective Agents, LocalCaliforniaChlorhexidineEndemic DiseasesGram-Positive Bacterial InfectionsHand HygieneHumansInfection ControlMethicillin-Resistant Staphylococcus aureusProtective ClothingRegression AnalysisRetrospective StudiesStaphylococcal InfectionsAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconate

Identifiers

PMID27457254
PMCPMC6783805
OpenAlexW2489212025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.